Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sally Wheelwright

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
The Lancet. Oncology|February 11, 2024
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trialCarlo Palmieri, Hannah Linden, Stephen N Birrell, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2022
Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancerKim Cocks, Jane R Wells, Colin Johnson, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 19, 2021
Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature reviewCecilie Delphin Amdal, Madeline Pe, Ragnhild Sørum Falk, et al.
Journal of Patient-Reported Outcomes|March 29, 2022
Health-related quality of life in patients with COVID-19; international development of a patient-reported outcome measureCecilie Delphin Amdal, Katherine Taylor, Dagmara Kuliś, et al.
European Journal of Cancer (Oxford, England : 1990)|January 16, 2026
Assessing quality of life in individuals with hereditary cancer risk: Results from phases 1-3a of the EORTC QLQ-HCR30 questionnaireVeronika I Engele, Vassilios Vassiliou, Sally Wheelwright, et al.
European Journal of Cancer (Oxford, England : 1990)|April 7, 2025
Flexibility in patient-reported outcome and health-related quality of life measurement: The EORTC Quality of Life Group measurement strategyClaire Piccinin, Neil K Aaronson, Kristin Bjordal, et al.
The Lancet. Oncology|December 15, 2024
Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trialIcro Meattini, Maria Carmen De Santis, Luca Visani, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
The Lancet. Oncology|February 11, 2024
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trialCarlo Palmieri, Hannah Linden, Stephen N Birrell, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2022
Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancerKim Cocks, Jane R Wells, Colin Johnson, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 19, 2021
Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature reviewCecilie Delphin Amdal, Madeline Pe, Ragnhild Sørum Falk, et al.
Journal of Patient-Reported Outcomes|March 29, 2022
Health-related quality of life in patients with COVID-19; international development of a patient-reported outcome measureCecilie Delphin Amdal, Katherine Taylor, Dagmara Kuliś, et al.
European Journal of Cancer (Oxford, England : 1990)|January 16, 2026
Assessing quality of life in individuals with hereditary cancer risk: Results from phases 1-3a of the EORTC QLQ-HCR30 questionnaireVeronika I Engele, Vassilios Vassiliou, Sally Wheelwright, et al.
European Journal of Cancer (Oxford, England : 1990)|April 7, 2025
Flexibility in patient-reported outcome and health-related quality of life measurement: The EORTC Quality of Life Group measurement strategyClaire Piccinin, Neil K Aaronson, Kristin Bjordal, et al.
The Lancet. Oncology|December 15, 2024
Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trialIcro Meattini, Maria Carmen De Santis, Luca Visani, et al.
Pageof 8